Summary: Researchers have identified three indole-based compounds produced by the blood bacterium Paracoccus sanguinis that show protective effects against processes linked to skin aging. In cultured human skin cells, these metabolites lowered markers of inflammation, oxidative stress and collagen breakdown—key drivers of aged-looking skin.
Two of the three active molecules are newly discovered, making them promising leads for future anti-aging therapies. The findings suggest that metabolites from microbes circulating in the bloodstream can influence skin health in unexpected ways.
Key Facts:
- New anti-aging candidates: Three indole metabolites reduced inflammation and collagen-degrading activity in human skin cell cultures.
- Blood-borne source: All compounds were produced by Paracoccus sanguinis, a bacterium isolated from human blood.
- Novel chemistry: Two of the skin-protective indole molecules were previously unknown to science.
Source: ACS
Maintaining youthful skin drives a large global market for topical masks, creams and serums. This research highlights a different source of potential skin-protective agents: small molecules generated by microbes living in the bloodstream. The study shows that certain indole-containing metabolites from P. sanguinis can reduce oxidative stress and inflammation in human dermal cells, processes that contribute to visible skin aging.
Published in the Journal of Natural Products, the study used a combination of cultivation, chemical analysis and cellular testing to profile the metabolites produced by Paracoccus sanguinis and to assess their effects on human skin cells. The work provides new evidence that blood-derived microbial metabolites can exert biologically relevant effects outside the gut, including on skin physiology.
Indole compounds have attracted attention for their diverse biological activities, including anti-inflammatory and antimicrobial effects. After P. sanguinis was first identified in 2015 as a blood-associated bacterium that produces indole-containing molecules, the authors—Chung Sub Kim, Sullim Lee and colleagues—set out to characterize the organism’s metabolome and to test whether its products influence skin-related aging processes.
The researchers cultured a large volume of P. sanguinis for three days and extracted the complex mixture of secreted metabolites. Using mass spectrometry, isotope-labeling experiments and computational analyses, they resolved the complex extract into 12 distinct indole-functionalized metabolites, six of which had not been described previously.
To test anti-aging activity, each purified indole compound was applied to wells containing cultured normal human dermal fibroblasts (NHDFs). The cells had been stimulated with a pro-inflammatory factor to raise levels of reactive oxygen species (ROS), which are known to promote inflammation and degrade collagen through matrix metalloproteinases like MMP-1.
Of the 12 metabolites tested, three—including two newly identified molecules—significantly reduced ROS levels in the stressed skin cells compared with untreated controls. Those same compounds also lowered secretion of MMP-1 and reduced the inflammatory cytokines interleukin-6 (IL-6) and interleukin-8 (IL-8), indicating a multi-faceted protection against cellular changes linked to skin aging.
Among the active molecules, one compound (referred to as 11 in the study) showed the strongest effects across the measured endpoints, making it a particularly promising candidate for further investigation as a topical or systemic agent to counteract skin aging.
The authors emphasize that these are early-stage results obtained in cell culture. Still, the discovery of bioactive indole metabolites from a blood-derived microbe expands our understanding of how the human microbiome—beyond the gut—can influence tissue function and suggests new avenues for developing anti-aging skin treatments based on microbial chemistry.
Funding: The research team acknowledges support from the National Research Foundation of Korea, the BK21 FOUR Project and the National Supercomputing Center.
About this aging research news
Author: ACS Newsroom
Source: ACS
Contact: ACS Newsroom – ACS
Image: The image is credited to Neuroscience News
Original Research: Closed access. “Discovery and Biosynthesis of Indole-Functionalized Metabolites from the Human Blood Bacterium, Paracoccus sanguinis, and Their Anti-Skin Aging Activity” by Chung Sub Kim et al., Journal of Natural Products.
Abstract
Discovery and Biosynthesis of Indole-Functionalized Metabolites from the Human Blood Bacterium, Paracoccus sanguinis, and Their Anti-Skin Aging Activity
The human microbiome influences health through microbial metabolites that mediate physiological processes. While gut microbiota have been extensively studied, the metabolic roles of bacteria isolated from blood remain poorly understood. This study characterizes the metabolome of the facultative anaerobe Paracoccus sanguinis, a Gram-negative bacterium sourced from human blood, and evaluates the skin-related bioactivities of its metabolites.
Using advanced analytical chemistry and biosynthetic tracing, researchers identified 12 indole-derived metabolites, six of which are novel. Biosynthetic analyses indicate these molecules arise via both enzymatic and non-enzymatic pathways. Functional assays in TNF-α-stimulated normal human dermal fibroblasts demonstrated that compounds labeled 1, 6 and 11 suppressed reactive oxygen species, inhibited MMP-1 secretion, and reduced inflammatory cytokines IL-6 and IL-8.
Compound 11 exhibited the most pronounced anti-aging activity among the tested metabolites, suggesting its potential as a lead for therapeutic development aimed at skin aging. Overall, this work reveals biosynthetic pathways in P. sanguinis and highlights the capacity of blood-derived microbial metabolites to modulate skin health, offering new directions for research into microbiome-derived interventions for aging.